Lotte Chemical Accelerates Asset-Light Strategy with Divestiture of Water Treatment Business

Reporter Paul Lee / approved : 2025-06-20 09:47:47
  • -
  • +
  • 인쇄

Photo = Lotte Chemical

 

 

[Alpha Biz= Paul Lee] SEOUL, June 20, 2025 — Lotte Chemical is ramping up its asset-light strategy and business restructuring by offloading non-core operations. The company announced on Thursday that it will sell its water treatment membrane manufacturing plant in Daegu to Sinoporex Membrane.



Following the signing of a business transfer agreement, both parties aim to complete the deal next month, pending fulfillment of key conditions. The transaction value remains undisclosed under a confidentiality agreement.



The Daegu plant began full-scale commercial production in 2019 and specializes in manufacturing and selling ultra-filtration (UF) membranes used for wastewater treatment (including municipal and industrial) and water purification (for potable and industrial use).



This move is part of Lotte Chemical’s broader asset-light transformation, which has already generated approximately KRW 1.7 trillion in liquidity this year. In the first half of 2025, the company sold its entire 75.01% stake in its Pakistani PTA subsidiary, LOTTE CHEMICAL Pakistan Limited (LCPL), securing about KRW 97.9 billion. It also raised KRW 650 billion by leveraging its 25% stake in Indonesian subsidiary PT Lotte Chemical Indonesia (LCI) and sold a 4.9% stake in Japan-based Resonac for KRW 275 billion.



Lotte Chemical says the strategy will allow it to focus on high-value core businesses while strengthening financial flexibility.

 

 

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

어플

주요기사

NAVER Secures 60,000 NVIDIA Blackwell GPUs to Lead Industrial AI Innovation2025.11.01
Shinhan Investment Raises LG Innotek Target Price to ₩280,000 on Earnings Recovery and 2025 Growth Outlook2025.10.31
Woori Bank Sanctioned by Financial Supervisory Service for Delayed Reporting of Overseas Regulatory Actions2025.10.31
Samyang Foods Raises U.S. Supply Prices for Buldak Ramen Amid Tariff Impact2025.10.31
NH Investment & Securities Suspends IB Executive Under Investigation for Alleged Insider Trading2025.10.31
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사